HBK Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-6,000
| Closed | -$428K | – | 1044 |
|
|
2018
Q4 | $428K | Sell |
6,000
-2,883
| -32% | -$206K | ﹤0.01% | 831 |
|
|
2018
Q3 | $1.09M | Sell |
8,883
-7,599
| -46% | -$934K | 0.01% | 583 |
|
|
2018
Q2 | $1.62M | Buy |
+16,482
| New | +$1.62M | 0.01% | 471 |
|
|
2017
Q1 | – | Sell |
-11,300
| Closed | -$437K | – | 710 |
|
|
2016
Q4 | $437K | Buy |
+11,300
| New | +$437K | ﹤0.01% | 507 |
|
|
2016
Q3 | – | Sell |
-42,267
| Closed | -$1.92M | – | 878 |
|
|
2016
Q2 | $1.92M | Buy |
42,267
+27,679
| +190% | +$1.26M | 0.01% | 376 |
|
|
2016
Q1 | $577K | Sell |
14,588
-25,812
| -64% | -$1.02M | 0.01% | 646 |
|
|
2015
Q4 | $2.29M | Sell |
40,400
-75,734
| -65% | -$4.28M | 0.02% | 313 |
|
|
2015
Q3 | $4.62M | Buy |
+116,134
| New | +$4.62M | 0.05% | 182 |
|
|
2014
Q2 | – | Sell |
-46,500
| Closed | -$749K | – | 948 |
|
|
2014
Q1 | $749K | Sell |
46,500
-25,700
| -36% | -$414K | 0.01% | 515 |
|
|
2013
Q4 | $674K | Buy |
72,200
+15,700
| +28% | +$147K | 0.01% | 543 |
|
|
2013
Q3 | $640K | Sell |
56,500
-2,400
| -4% | -$27.2K | 0.01% | 531 |
|
|
2013
Q2 | $788K | Buy |
+58,900
| New | +$788K | 0.01% | 438 |
|